National Institute for Health and Clinical Excellence (NICE)
NICE launches online resource to help development and adoption of new health technologies
HealthTech Connect, a new online resource provided by NICE to help identify and support new health technologies as they move from inception to adoption in the UK health and care system was formally launched today (29 April).
Developed by NICE with help from a range of partner organisationsi and funding from NHS England, HealthTech Connect is for health technologies (medical devices and diagnostic and digital health technologies) that:
- offer measurable benefits to patients (or other health and care service users) compared to those already offered by current routine practice in the UK, or
- provide measurable benefits to the UK health and care system compared to those already offered by current routine practice in the UK.
The system, which is free to use, will help companies to understand what information is needed by decision makers in the UK health and care system, and clarify possible routes to market access. It will also help the UK health and care system to better plan for the introduction and adoption of health technologies - for example by reconfiguring services or enabling reimbursement.
Once registered, companies enter and update information about their technology as it develops into www.HealthTechConnect.org.uk. This information is used to determine if the technology is suitable for consideration by an organisation that offers support to health technology developers; for example with funding, technology development, evidence generation, market access, reimbursement, adoption.
It will also be used to identify if the technology is suitable for consideration for evaluation by a UK health technology assessment programme.
Technologies that are suitable for support or evaluation will be able to access this through HealthTech Connect. This will avoid companies having to provide the same or similar information about their technology separately to a different organisation or programme.
Meindert Boysen, director of the Centre for Health technology Evaluation at NICE, said: “HealthTech Connect is a clear and simple point of entry for companies developing health technologies, be it medical devices, diagnostics or digital health technologies, to access support and potential routes to national evaluation programmes.
“As well as helping national organisations like NICE, that have a responsibility for developing guidance on the use of health technologies in the NHS, better identify and track technologies that offer novel benefits, HealthTech Connect will also enable transformative technologies to be identified and fast tracked through relevant processes within the Accelerated Access Collaborative.
“Ultimately the aim of HealthTech Connect is to help get promising new health technologies to the people who will benefit from them, faster. We expect it to contribute to reducing the complexity, and often duplication, involved in getting medical devices, diagnostics and digital health technologies adopted in the UK.”
Since the initial “soft” launch of the system in February, over 100 companies have registered to use HealthTech Connect, 13 technologies have been submitted, and 1 technology [Sonata System] has already been selected by NICE for a Medtech Innovation Briefing
Sarah Field, sales manager UK & Ireland for Gynesonics, said: “The HealthTech Connect portal was a great way to interface the interaction between our organisation and NICE. This enabled a swift pathway for our new technology (the Sonata treatmentii) to be evaluated. I thoroughly recommend other commercial organisations to use this route. The registration process was quick and simple. This is a really helpful initiative.”
Further information about HealthTech Connect is available at the HealthTech Connect website
- ABHI, AXREM, BIVDA), NIHR and the NIHR Innovation Observatory, the AHSN network, Office for Life Sciences, MHRA, NHS Clinical Commissioners, NHS Supply chain and the devolved administrations in Wales, Scotland, and Northern Ireland.
- The Sonata System combines real-time intrauterine ultrasound guidance with targeted radiofrequency ablation in an incisionless procedure to treat symptomatic uterine fibroids.
Latest News from
National Institute for Health and Clinical Excellence (NICE)
Another treatment option for ovarian cancer approved for the Cancer Drugs Fund11/10/2019 16:05:00
An ovarian cancer treatment, designed to help maintain the effects of chemotherapy, has been approved by NICE for use in the Cancer Drugs Fund (CDF)
NICE looks to company to ensure a new treatment for advanced breast cancer with significant unmet need is cost-effective04/10/2019 13:10:00
Draft guidance published yesterday (4 October 2019) by NICE does not recommend atezolizumab (also called Tecentriq and made by Roche) for treating people with a type of breast cancer called triple A breast cancer that has spread to other parts of the body and who can’t have surgery to remove it.
Procedure carried out on unborn babies with spina bifida could improve their neurodevelopment27/09/2019 16:15:00
Operations are set to start taking place in the NHS.
More than one thousand neonatal admissions could be avoided per year by following NICE guidance27/09/2019 09:15:00
Regularly monitoring women who are pregnant with twins or triplets, to spot any possible complications, can lead to better outcomes for mothers and their babies, as highlighted in NICE’s impact report.
Migraine drug not cost effective NICE says in final draft guidance26/09/2019 17:11:00
NICE has said that a new drug for preventing migraine is not a cost effective use of NHS resources, in final draft guidance published today (26 September 2019).
Food on a restricted renal diet can still be hugely fun and enjoyable26/09/2019 11:15:00
Blog posted by: Deborah Duval, the editor of Kidney Matters magazine, tells us how we can enjoy food even on a restricted renal diet, 25 September 2019.
NICE seeks feedback from users of the evidence standards framework for digital health technologies24/09/2019 11:15:00
Consultation on priority areas open to stakeholders until mid October.
NICE calls for further research on management options for tinnitus23/09/2019 12:15:00
Higher quality evidence would allow NICE to make recommendations on a range of therapies that could help people with tinnitus.